These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1893643)

  • 21. Clinical pharmacology of ACE inhibition.
    Nussberger J; Waeber B; Brunner HR
    Cardiology; 1989; 76 Suppl 2():11-22. PubMed ID: 2670217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.
    Brunner HR; Waeber B; Nussberger J
    J Hypertens Suppl; 1988 Dec; 6(3):S1-5. PubMed ID: 3066876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme in cardiovascular and adrenal tissues and implications for successful blood pressure management.
    Melby JC
    Am J Cardiol; 1992 Apr; 69(10):2C-7C. PubMed ID: 1546636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
    Burnier M
    Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
    Waeber B; Nussberger J; Juillerat L; Brunner HR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of reflexes from volume and baroreceptors during converting-enzyme inhibition in humans.
    Giannattasio C; Grassi G; Seravalle G; Morganti A; Zanchetti A; Mancia G
    Am Heart J; 1989 Mar; 117(3):740-5. PubMed ID: 2645757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development.
    Buttar HS
    Mol Cell Biochem; 1997 Nov; 176(1-2):61-71. PubMed ID: 9406146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of the renin-angiotensin-aldosterone system and cough.
    Lacourcière Y; Lefebvre J
    Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-atherosclerotic action of ACE inhibitors. I. Inactivation of the renin-angiotensin system].
    Stajszczyk M; Gmiński J
    Postepy Hig Med Dosw; 1996; 50(2):157-71. PubMed ID: 8848424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal prostaglandin synthesis and angiotensin-converting enzyme inhibition.
    Wilson TW
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S39-44. PubMed ID: 1382164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension].
    Khadartsev AA; Logatkina AV; Terekhov IV; Bondar SS; Bondar NV
    Ter Arkh; 2017; 89(12):97-102. PubMed ID: 29411767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin converting enzyme inhibitors reduce alcohol consumption: some possible mechanisms and important conditions for its therapeutic use.
    Lingham T; Perlanski E; Grupp LA
    Alcohol Clin Exp Res; 1990 Feb; 14(1):92-9. PubMed ID: 2178480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-converting enzyme in renal and cerebral tissue and implications for successful blood pressure management.
    Reams GP
    Am J Cardiol; 1992 Apr; 69(10):59C-64C. PubMed ID: 1312296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mechanisms of hypertension and the role of ACE inhibitors.
    Kureya P; Beevers DG
    J Hum Hypertens; 1991 Dec; 5 Suppl 2():3-8. PubMed ID: 1791616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.